Don’t Blame Biden for Trump’s Victory
Readers respond to a guest essay by Josh Barro. Also: Elon Musk and America’s birthrate; a pharmacist’s view; the danger of extreme heat.
Court Hears New York Times Case Against European Commission Over Vaccine Deal
The news outlet is pushing the Commission to release text messages between the E.U.’s top official and Pfizer as they negotiated a Covid-19 vaccine contract.
Can America’s Health Survive Robert F. Kennedy Jr.?
What Kennedy gets right.
Ozempic Could Prevent Diabetes. Should We Use It For That?
New research shows that weight loss medications can stop the progression of prediabetes. Experts don’t all agree on such a use for the drugs.
What Democrats Should Learn From Their Loss
Readers point to campaign missteps and offer advice for winning back voters. Also: Robert F. Kennedy Jr.’s role in health policy; closing local pharmacies.
Venom Helped Create Weight-Loss Drugs. What Else Could It Do For Us?
A study of Gila monster venom helped start the revolution in weight-loss drugs. But scientists think that’s just the beginning.
What to Know About Plan B: Cost, Effectiveness and Legality
We asked experts how it works, when you should take it, how much it costs and more.
Richard Pazdur, FDA Cancer Chief, Discusses 25 Years of Innovation
Dr. Richard Pazdur for 25 years has overseen innovations in the treatment of deadly diseases at the agency.
F.D.A. Wants to Pull Ineffective Decongestant From Stores
It was added to cold and flu remedies in the 1990s when another ingredient went behind the counter over illicit meth lab concerns.
El medicamento innovador para vencer la adicción: ¿Ozempic?
Los primeros datos sugieren que los fármacos GLP-1, conocidos por su capacidad para ayudar a perder peso, podrían tener un poderoso efecto en el tratamiento de la adicción.
Call for more information
888-531-0245
info@siii-clinical.com
From research laboratories to clinical settings, SIII integrates the technologies, resources, and expertise our customers need to rise to the next opportunity. SIII is dedicated to exploring and researching the processes and scientific mechanisms underlying the world we live in.